IL109094A0 - Human tnf muteins - Google Patents

Human tnf muteins

Info

Publication number
IL109094A0
IL109094A0 IL10909494A IL10909494A IL109094A0 IL 109094 A0 IL109094 A0 IL 109094A0 IL 10909494 A IL10909494 A IL 10909494A IL 10909494 A IL10909494 A IL 10909494A IL 109094 A0 IL109094 A0 IL 109094A0
Authority
IL
Israel
Prior art keywords
human tnf
tnf muteins
muteins
human
tnf
Prior art date
Application number
IL10909494A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL109094A0 publication Critical patent/IL109094A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL10909494A 1993-03-29 1994-03-23 Human tnf muteins IL109094A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810224 1993-03-29

Publications (1)

Publication Number Publication Date
IL109094A0 true IL109094A0 (en) 1994-06-24

Family

ID=8214942

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10909494A IL109094A0 (en) 1993-03-29 1994-03-23 Human tnf muteins

Country Status (14)

Country Link
US (1) US5597899A (pt)
EP (1) EP0619372A1 (pt)
JP (1) JPH089976A (pt)
CN (1) CN1099802A (pt)
AU (1) AU5901994A (pt)
BR (1) BR9401321A (pt)
CA (1) CA2119089A1 (pt)
CZ (1) CZ67694A3 (pt)
FI (1) FI941459A (pt)
HU (1) HUT68218A (pt)
IL (1) IL109094A0 (pt)
NO (1) NO941142L (pt)
NZ (1) NZ260146A (pt)
RU (1) RU94009852A (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199802238T2 (xx) * 1996-05-08 1999-02-22 F. Hoffmann-La Roche Ag Astımın TNFR-Ig ile tedavisi.
PL194221B1 (pl) * 1997-04-15 2007-05-31 Pharmexa As Zmodyfikowana cząsteczka ludzkiego TNFalfa, dimery, oligomery lub multimery zmodyfikowanej cząsteczki ludzkiego TNFalfa, wyizolowana cząsteczka DNA, wektor, wektor ekspresyjny, komórka gospodarza, sposób wytwarzania zmodyfikowanej cząsteczki ludzkiego TNFalfa, szczepionki przeciwko TNFalfa oraz zastosowanie przynajmniej jednej zmodyfikowanej cząsteczki ludzkiego TNFalfa
CN1062274C (zh) * 1997-10-07 2001-02-21 复旦大学 人肿瘤坏死因子α衍生物及其制备方法
US6354297B1 (en) * 1998-04-16 2002-03-12 The Uniformed Services University Of The Health Sciences Method and device for destroying fat cells by induction of programmed cell death
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
US7662367B2 (en) * 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
US20070172449A1 (en) * 2000-03-02 2007-07-26 Xencor, Inc. TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
US7687461B2 (en) * 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US7244823B2 (en) * 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
WO2003057856A2 (en) * 2002-01-04 2003-07-17 Xencor Dominant negative proteins and methods thereof
US7179891B2 (en) * 2002-03-25 2007-02-20 Tadanori Mayumi Physiologically active complex
JP4177604B2 (ja) * 2002-03-25 2008-11-05 株式会社林原生物化学研究所 生理活性複合体
WO2004050683A2 (en) * 2002-12-02 2004-06-17 Abgenix, Inc. Antibodies directed to tumor necrosis factor and uses thereof
TWI364295B (en) * 2002-12-26 2012-05-21 Mountain View Pharmaceuticals Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
US7642340B2 (en) * 2003-03-31 2010-01-05 Xencor, Inc. PEGylated TNF-α variant proteins
AU2004279895A1 (en) 2003-10-10 2005-04-21 Xencor, Inc Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders
TW201122103A (en) * 2004-01-06 2011-07-01 Hayashibara Biochem Lab Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
CA2565215C (en) * 2004-04-30 2014-04-15 Biopheresis Technologies, Inc. Method and system to remove soluble tnfr1, tnfr2, and il2 in patients
GB0425972D0 (en) 2004-11-25 2004-12-29 Celltech R&D Ltd Biological products
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
WO2008127515A1 (en) * 2007-03-01 2008-10-23 Cytologic, Inc. Compositions and method for enhancing immune responses in mammals
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
CN106540252B (zh) * 2016-12-07 2020-04-28 四川大学 针对肿瘤坏死因子α的蛋白疫苗及其用途
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope
AU2018247931B2 (en) * 2017-04-06 2022-03-03 Universität Stuttgart Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivity
WO2022266507A1 (en) 2021-06-17 2022-12-22 Immunicom, Inc. Modified tnf as a capture ligand

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
EP0155549B1 (en) * 1984-03-06 1991-03-20 Dainippon Pharmaceutical Co., Ltd. Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
GR851626B (pt) * 1984-07-05 1985-11-26 Genentech Inc
DE3750056T2 (de) * 1986-06-20 1995-04-06 Dainippon Pharmaceutical Co Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
JPH07106158B2 (ja) * 1986-12-04 1995-11-15 サントリー株式会社 抗腫瘍活性を有する新規ポリペプチドおよびその製造法
WO1988006625A2 (en) * 1987-02-26 1988-09-07 Cetus Corporation Arginine-depleted human tumor necrosis factor
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
CA2055168A1 (en) * 1990-11-21 1992-05-22 Walter Fiers Tnf-muteins
IL99120A0 (en) * 1991-08-07 1992-07-15 Yeda Res & Dev Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them
CZ283533B6 (cs) * 1992-04-02 1998-04-15 F. Hoffmann-La Roche Ag TNF - muteiny a způsob jejich výroby

Also Published As

Publication number Publication date
NO941142L (no) 1994-09-30
RU94009852A (ru) 1996-07-20
NZ260146A (en) 1995-10-26
EP0619372A1 (en) 1994-10-12
FI941459A0 (fi) 1994-03-29
CA2119089A1 (en) 1994-09-30
AU5901994A (en) 1994-10-06
CN1099802A (zh) 1995-03-08
FI941459A (fi) 1994-09-30
BR9401321A (pt) 1994-10-18
US5597899A (en) 1997-01-28
CZ67694A3 (en) 1995-02-15
HU9400829D0 (en) 1994-06-28
HUT68218A (en) 1995-06-28
JPH089976A (ja) 1996-01-16
NO941142D0 (no) 1994-03-28

Similar Documents

Publication Publication Date Title
IL109094A0 (en) Human tnf muteins
IL106732A0 (en) Human interleukin-13
ZA936097B (en) Human interleukin-13
HU9400190D0 (en) Therapeutic compositions and methods
GB9312204D0 (en) Therapeutic composition
AU120796S (en) Chair
GB9307013D0 (en) Therapeutic combinations
ZA946217B (en) Therapeutic combination
HU9200644D0 (en) Medical preparatives
AU121086S (en) Chair
EP0797592A4 (en) HUMAN STANNIOCALCIN ALPHA
AU119673S (en) Chair
GB2292219B (en) Polymorphisms in human phosphoglucomutase-1
GB9305316D0 (en) Skin emollinets
ZA947865B (en) Human glactokinase
EP0795006A4 (en) HUMAN MuT2
IL97169A0 (en) Skin gel
GB9306646D0 (en) Therapeutic agetns
GB9308962D0 (en) Therapeutic agetns
GB9302197D0 (en) Non-invasive bilirubinometer
HU9201252D0 (en) Medical filtering-diagnosticizing unit
GB9210576D0 (en) Medical use
GB9210595D0 (en) Medical use
GB9210594D0 (en) Medical use
GB9220714D0 (en) Therapeutic use